HomeABC • VIE
add
Cencora Inc
Previous close
€305.60
Day range
€298.40 - €302.30
Year range
€230.55 - €330.40
Market cap
15.88B USD
Avg Volume
4.00
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 85.93B | 5.45% |
Operating expense | 2.06B | 15.22% |
Net income | 559.65M | 14.54% |
Net profit margin | 0.65 | 8.33% |
Earnings per share | 4.08 | 9.38% |
EBITDA | 1.27B | 23.07% |
Effective tax rate | 20.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.75B | -45.63% |
Total assets | 78.36B | 13.48% |
Total liabilities | 76.27B | 11.02% |
Total equity | 2.10B | — |
Shares outstanding | 194.53M | — |
Price to book | 31.15 | — |
Return on assets | 3.25% | — |
Return on capital | 21.82% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 559.65M | 14.54% |
Cash from operations | -2.31B | 15.21% |
Cash from investing | -299.32M | 12.75% |
Cash from financing | 43.20M | -98.65% |
Net change in cash | -2.59B | -2,763.25% |
Free cash flow | -2.71B | 7.84% |
About
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. Wikipedia
Founded
1871
Website
Employees
49,000
